The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 14, 2016
Filed:
Aug. 31, 2011
Applicants:
Daniele Andreotti, Verona, IT;
Xuedong Dai, Shanghai, CN;
Andrew John Eatherton, Middlesex, GB;
Karamjit Singh Jandu, Middlesex, GB;
Qian Liu, Shanghai, CN;
Oliver James Philps, Middlesex, GB;
Inventors:
Daniele Andreotti, Verona, IT;
Xuedong Dai, Shanghai, CN;
Andrew John Eatherton, Middlesex, GB;
Karamjit Singh Jandu, Middlesex, GB;
Qian Liu, Shanghai, CN;
Oliver James Philps, Middlesex, GB;
Assignee:
Glaxo Group Limited, Brentford, Middlesex, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 213/75 (2006.01); C07D 231/12 (2006.01); C07D 237/20 (2006.01); C07D 261/14 (2006.01); C07D 295/192 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); C07D 213/75 (2013.01); C07D 231/12 (2013.01); C07D 237/20 (2013.01); C07D 261/14 (2013.01); C07D 295/192 (2013.01); C07D 401/12 (2013.01); C07D 413/12 (2013.01);
Abstract
The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterized by LRRK2 kinase activity, for example Parkinson's disease or Alzheimer's disease.